- Home
- Publications
- Publication Search
- Publication Details
Title
Comparative Tolerability and Harms of Individual Statins
Authors
Keywords
-
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2013-07-10
DOI
10.1161/circoutcomes.111.000071
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Narrative Review: Statin-Related Myopathy
- (2013) Tisha R. Joy ANNALS OF INTERNAL MEDICINE
- Comparative effects of statins on major cerebrovascular events: a multiple-treatments meta-analysis of placebo-controlled and active-comparator trials
- (2013) H. Naci et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- Dose-comparative effects of different statins on serum lipid levels: a network meta-analysis of 256,827 individuals in 181 randomized controlled trials
- (2013) Huseyin Naci et al. European Journal of Preventive Cardiology
- Comparative benefits of statins in the primary and secondary prevention of major coronary events and all-cause mortality: a network meta-analysis of placebo-controlled and active-comparator trials
- (2013) Huseyin Naci et al. European Journal of Preventive Cardiology
- Evidence-based Use of Statins for Primary Prevention of Cardiovascular Disease
- (2012) C. Michael Minder et al. AMERICAN JOURNAL OF MEDICINE
- Healthy Men Should Not Take Statins
- (2012) Mitchell H. Katz JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Meta-Analysis of Statin Effects in Women Versus Men
- (2012) William J. Kostis et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Statins for all by the age of 50 years?
- (2012) Shah Ebrahim et al. LANCET
- Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial
- (2012) Paul M Ridker et al. LANCET
- Personalized Prediction of Lifetime Benefits with Statin Therapy for Asymptomatic Individuals: A Modeling Study
- (2012) Bart S. Ferket et al. PLOS MEDICINE
- Statin myopathy: A common dilemma not reflected in clinical trials
- (2011) G. FERNANDEZ et al. CLEVELAND CLINIC JOURNAL OF MEDICINE
- Risk of Incident Diabetes With Intensive-Dose Compared With Moderate-Dose Statin Therapy
- (2011) David Preiss JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Adverse events associated with individual statin treatments for cardiovascular disease: an indirect comparison meta-analysis
- (2011) M. Alberton et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- Diagnostic Tests: Another Frontier for Less Is More
- (2010) Rita Redberg et al. ARCHIVES OF INTERNAL MEDICINE
- Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial
- (2010) Georgia Salanti et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
- (2010) Naveed Sattar et al. LANCET
- A basic introduction to fixed-effect and random-effects models for meta-analysis
- (2010) Michael Borenstein et al. Research Synthesis Methods
- Statin Therapy and Risk of Developing Type 2 Diabetes: A Meta-Analysis
- (2009) S. N. Rajpathak et al. DIABETES CARE
- Addressing between-study heterogeneity and inconsistency in mixed treatment comparisons: Application to stroke prevention treatments in individuals with non-rheumatic atrial fibrillation
- (2009) Nicola J. Cooper et al. STATISTICS IN MEDICINE
- Comparison of Benefits and Risks of Rosuvastatin Versus Atorvastatin from a Meta-Analysis of Head-to-Head Randomized Controlled Trials
- (2008) John Wlodarczyk et al. AMERICAN JOURNAL OF CARDIOLOGY
- Statins and cancer: A systematic review and meta-analysis
- (2008) Jaana Kuoppala et al. EUROPEAN JOURNAL OF CANCER
- Statins for Secondary Prevention in Elderly Patients
- (2008) Jonathan Afilalo et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started